Ko Okumura Selected Research

Ko Okumura Research Topics

Disease

56	Inflammation (Inflammations) 01/2022 - 05/2002
30	Hypersensitivity (Allergy) 01/2021 - 05/2002
28	Neoplasms (Cancer) 02/2022 - 01/2002
18	Asthma (Bronchial Asthma) 01/2021 - 08/2002
17	Atopic Dermatitis (Atopic Eczema) 01/2022 - 12/2002
13	Infections 03/2016 - 06/2003
12	Eosinophilia 01/2021 - 10/2003
10	Wounds and Injuries (Trauma) 01/2022 - 03/2003
10	Colitis 05/2016 - 02/2003
8	type 2C Congenital disorder of glycosylation 01/2022 - 04/2010
8	Contact Dermatitis (Eczema, Contact) 11/2018 - 10/2003
7	Anaphylaxis (Anaphylactic Shock) 01/2018 - 05/2002
7	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2015 - 12/2002
6	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 10/2021 - 07/2002
6	Neoplasm Metastasis (Metastasis) 03/2021 - 09/2003
6	Food Hypersensitivity (Food Allergy) 01/2021 - 06/2005
6	Virus Diseases (Viral Diseases) 05/2018 - 01/2009
6	Necrosis 06/2012 - 01/2002
5	Reperfusion Injury 01/2021 - 12/2005
5	Arthritis (Polyarthritis) 01/2019 - 10/2002
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2011 - 08/2002
5	Rheumatoid Arthritis 03/2010 - 10/2002
5	Skin Diseases (Skin Disease) 01/2009 - 12/2002
4	Hyperplasia 03/2017 - 02/2007
4	Experimental Arthritis 03/2011 - 10/2002
3	Hypoxia (Hypoxemia) 02/2022 - 09/2015
3	Ischemia 01/2021 - 05/2010
3	Fibrosis (Cirrhosis) 12/2020 - 08/2004
3	Ischemic Stroke 01/2019 - 07/2009
3	Leukemia 01/2018 - 05/2002
3	Pneumonia (Pneumonitis) 12/2017 - 09/2012
3	Sepsis (Septicemia) 01/2017 - 05/2002
3	Fibrosarcoma 01/2017 - 10/2005
3	Respiratory Hypersensitivity 01/2015 - 12/2002
3	Autoimmune Diseases (Autoimmune Disease) 01/2015 - 06/2002
3	Hepatitis 12/2012 - 01/2009
3	Disease Progression 08/2009 - 08/2002
3	Myocarditis (Carditis) 07/2007 - 04/2002
3	Chagas Disease (American Trypanosomiasis) 11/2005 - 03/2003

Drug/Important Bio-Agent (IBA)

39	CytokinesIBA 01/2022 - 05/2002
32	Immunoglobulin E (IgE)IBA 01/2021 - 05/2002
25	AllergensIBA 10/2021 - 04/2003
20	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 01/2002
20	LigandsIBA 12/2015 - 01/2002
19	AntigensIBA 01/2021 - 05/2002
18	Monoclonal AntibodiesIBA 01/2022 - 01/2002
17	Proteins (Proteins, Gene)FDA Link 10/2021 - 10/2002
15	Interleukin-33IBA 01/2021 - 12/2009
14	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 01/2002
11	ChemokinesIBA 01/2022 - 12/2002
10	Thymic Stromal LymphopoietinIBA 01/2021 - 05/2007
10	OvalbuminIBA 01/2021 - 04/2003
10	Transforming Growth Factor beta (TGF-beta)IBA 09/2010 - 08/2002
9	TNF-Related Apoptosis-Inducing LigandIBA 01/2020 - 10/2002
8	Immunoglobulin G (IgG)IBA 01/2021 - 10/2002
8	AntibodiesIBA 01/2021 - 05/2002
7	PapainIBA 01/2021 - 05/2013
7	IgE Receptors (Fc epsilon RI)IBA 12/2020 - 07/2002
6	Therapeutic UsesIBA 01/2022 - 09/2003
6	Peptides (Polypeptides)IBA 01/2022 - 06/2005
6	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2020 - 02/2004
6	Dermatophagoides pteronyssinus antigen p 1IBA 12/2011 - 07/2005
5	Interleukin-13IBA 12/2020 - 10/2003
5	Messenger RNA (mRNA)IBA 11/2019 - 10/2003
4	Apoptosis Regulatory ProteinsIBA 12/2021 - 11/2016
4	Pharmaceutical PreparationsIBA 03/2021 - 03/2003
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 10/2012
4	Interleukin-1 (Interleukin 1)IBA 11/2019 - 10/2010
4	Interleukin-4 (Interleukin 4)IBA 11/2019 - 10/2003
4	HaptensIBA 11/2018 - 10/2003
4	VaccinesIBA 01/2018 - 03/2009
4	Dextrans (Dextran)FDA Link 05/2016 - 08/2010
4	Interleukin-10 (Interleukin 10)IBA 07/2013 - 10/2003
4	Dermatophagoides farinae antigen f 1IBA 05/2013 - 07/2005
4	Neutralizing AntibodiesIBA 12/2012 - 06/2005
4	MucinsIBA 03/2011 - 02/2007
4	Thromboplastin (Tissue Factor)IBA 02/2011 - 07/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2009 - 01/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2021 - 01/2016
3	EnzymesIBA 02/2021 - 01/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2020 - 05/2002
3	Interleukin-2 (IL2)IBA 01/2020 - 10/2003
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 08/2002
3	CeramidesIBA 01/2017 - 05/2016
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2016 - 08/2010
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2015 - 10/2012
3	CollagenIBA 11/2013 - 12/2005
3	Fas Ligand Protein (Fas Ligand)IBA 12/2012 - 01/2005
3	InterferonsIBA 12/2012 - 01/2002
3	Phosphotransferases (Kinase)IBA 08/2011 - 02/2007
3	Collagen Type II (Type II Collagen)IBA 05/2007 - 10/2002
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 06/2003
2	S100 Calcium Binding Protein A7IBA 02/2022 - 07/2008
2	Conditioned Culture MediaIBA 02/2022 - 09/2015
2	Tyrosine (L-Tyrosine)FDA Link 02/2022 - 09/2015
2	Streptozocin (Streptozotocin)FDA Link 01/2022 - 10/2010

Therapy/Procedure

14	Therapeutics 02/2022 - 08/2002
14	Immunotherapy 01/2021 - 04/2002
3	Ligation 01/2017 - 04/2005
3	Oral Administration 01/2008 - 06/2005